Oncoinvent ASA (KLDVK) — Net Asset Quality Index
Oncoinvent ASA (KLDVK) has a Net Asset Quality Index of 54.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr507.79 Million minus total liabilities of Nkr230.30 Million yields net assets of Nkr277.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore how large is Oncoinvent ASA's balance sheet for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Oncoinvent ASA Net Asset Quality Index Over Time (2021–2025)
This chart shows how Oncoinvent ASA's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 54.6%, representing net assets of Nkr277.49 Million against total assets of Nkr507.79 Million NOK. See Oncoinvent ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Oncoinvent ASA (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Oncoinvent ASA from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see KLDVK stock market capitalisation.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.6% | Nkr277.49 Million | Nkr507.79 Million | Nkr230.30 Million | ▼ -0.9 pp |
| 2024 | 55.5% | Nkr267.76 Million | Nkr482.47 Million | Nkr214.71 Million | ▼ -10.9 pp |
| 2023 | 66.4% | Nkr283.70 Million | Nkr427.47 Million | Nkr143.77 Million | ▲ +4.7 pp |
| 2022 | 61.6% | Nkr192.02 Million | Nkr311.53 Million | Nkr119.51 Million | ▼ -3.8 pp |
| 2021 | 65.5% | Nkr112.27 Million | Nkr171.53 Million | Nkr59.25 Million | — |